Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 71 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| EXACT Sciences Corporation | EXAS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 58.79 | 05:56:08 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 58.79 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 10 | 71 | - | 56.05 - 100.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 06:44:46 | 15 | $ 59.50 | USD |
EXACT Sciences (EXAS) Options Flow Summary
EXACT Sciences Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 10.67B | 181.53M | - | 2.58B | -204.15M | -1.12 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
EXACT Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EXAS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 62.84 | 65.00 | 58.40 | 61.37 | 1,880,544 | -4.05 | -6.44% |
| 1 Month | 69.06 | 79.62 | 58.40 | 69.26 | 3,141,762 | -10.27 | -14.87% |
| 3 Months | 62.49 | 79.62 | 56.05 | 64.49 | 2,511,961 | -3.70 | -5.92% |
| 6 Months | 61.52 | 79.62 | 56.05 | 65.31 | 2,072,466 | -2.73 | -4.44% |
| 1 Year | 63.55 | 100.77 | 56.05 | 72.29 | 1,835,656 | -4.76 | -7.49% |
| 3 Years | 135.00 | 140.18 | 29.27 | 68.48 | 1,933,557 | -76.21 | -56.45% |
| 5 Years | 95.69 | 159.54 | 29.27 | 80.78 | 1,902,500 | -36.90 | -38.56% |
EXACT Sciences Description
| Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in multi-cancer liquid biopsy cancer screening. |
